What is Hedia?
Hedia operates within the digital health sector, specializing in diabetes management solutions. Their primary offering, the Hedia Diabetes Assistant, is a class IIb medical device engineered to empower individuals with insulin-requiring diabetes to better manage their condition and enhance their quality of life. The company's strategy involves close collaboration with healthcare professionals and key stakeholders across the diabetes ecosystem to deliver impactful patient care tools. Through ongoing clinical research, Hedia aims to validate and refine its offerings, ensuring tangible health benefits for its user base.
How much funding has Hedia raised?
Hedia has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2024): $3.2M with participation from Business Angels
Key Investors in Hedia
Business Angels
An early-stage investment group focused on providing seed capital to promising startups in the health technology sector.
What's next for Hedia?
The recent major strategic investment signals a pivotal growth phase for Hedia. This capital infusion is likely to accelerate product development, expand market reach, and potentially fund further clinical validation studies. The company's focus on diabetes management, a significant and growing global health challenge, positions it well for future expansion. Hedia's commitment to integrating technology with clinical practice suggests a trajectory towards becoming a key player in the digital therapeutics market, with potential for further strategic partnerships and funding rounds as it scales its operations and impact.
See full Hedia company page
